Precigen Inc (PGEN) Page | The Online Investor

Precigen Inc (PGEN)

Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.

PGEN SEC Filing Email Alerts Service

PGEN — Key Stats (updated 22 HRs, 50 MINs ago)

Company Name:
Precigen Inc
Website:
www.precigen.com
Sector:
Biotechnology
Number of ETFs Holding PGEN:
16
Total Market Value Held by ETFs:
$15.83M
Total Market Capitalization:
$348.00M
% of Market Cap. Held by ETFs:
4.55%

PGEN — News

PGEN — Price Chart

PGEN — Current Quote

Quotes delayed 20 minutes

Free PGEN Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Avg. Broker Rec.

Buy (3.20 out of 4)
100th percentile

(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
PGEN Stock Forecast

Based on Zacks ABR data;
powered by Xignite

PGEN — Performance

Precigen Inc (PGEN) Page | The Online Investor Page | www.TheOnlineInvestor.com

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.